SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
77.00
Ask:
78.20
Spread: 1.20 (1.558%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

AGM Correction Statement

24 Sep 2018 07:00

RNS Number : 6310B
Accsys Technologies PLC
24 September 2018
 

 

AIM: AXS

Euronext Amsterdam: AXS

24 September 2018

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Correction to Annual General Meeting Statement

 

Accsys issues a correction to the statement issued on 18 September 2018 in advance of its Annual General Meeting.

 

The correct total revenue for the five months to 31 August 2018 is €25.6m (2017: €24.3m) (unaudited), not €26.7m as previously reported. This difference is due to minor corrections to the accounting for intercompany transactions and has no impact on profit. All other aspects of the AGM statement, including the increase in production volume, are correct and remain unchanged.

 

Accsys remains confident of meeting its full year expectations given the growth in the remainder of its financial year is driven primarily by the substantial increase in production and sales expected following the successful commissioning of the third Accoya® reactor in Arnhem during the period and with demand continuing to exceed current production capacity in Arnhem.

 

 

ACCSYS TECHNOLOGIES PLC ("Accsys" of "de Vennootschap")

 

Correctie naar aanleiding van de verklaring jaarlijkse algemene vergadering

 

Accsys geeft een correctie op de verklaring die is gedaan voorafgaand aan de Algemene Vergadering van Aandeelhouders op 18 september 2018.

 

De correcte totale omzet in de vijf maanden tot 31 augustus 2018 bedraagt €25.6 miljoen (2017: €24.3 miljoen) (niet gecontroleerd) en niet, zoals eerder gemeld €26.7 miljoen. Dit verschil is het gevolg van enkele kleine correcties bij de verwerking van intra-company transacties en heeft geen invloed op de winst. Alle overige aspecten zoals verwoord in de verklaring van de jaarlijkse algemene vergadering, inclusief toename van het productievolume zijn correct en blijven gehandhaafd.

 

Accsys blijft vol vertrouwen dat het aan de verwachtingen voor het gehele jaar kan voldoen omdat de groei in het resterende deel van het financiële jaar met name wordt veroorzaakt door de significante toename van de productie en verwachtte verkopen. Dit als gevolg van de succesvolle opstart van de derde Accoya® reactor in Arnhem eerder dit jaar. De vraag naar Accoya is nog steeds groter dan de huidige productiecapaciteit in Arnhem.

 

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

Hans Pauli, Executive Director, Corporate Development

via MHP Communications

Numis Securities

Nominated Adviser:

Jamie Lillywhite

 

Corporate Broking:

Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

Kelsey Traynor

+44 (0) 20 3128 8100

Off the Grid (The Netherlands)

Frank Neervoort

Yvonne Derkse

+31 681 734 236

+31 622 379 666

 

 

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and Tricoya® wood elements, technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc.) and technology licensing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise four principal business units: (i) Accoya® wood production; (ii) building and operating of Tricoya® wood chip acetylation plant in Hull; (iii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iv) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® Wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a highly sustainable and environmentally responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of naturally occurring 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

Accsys Technologies is the trading name of Titan Wood Limited. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSESFADFASELU
Date   Source Headline
27th Jun 20114:40 pmRNSSecond Price Monitoring Extn
27th Jun 20114:35 pmRNSPrice Monitoring Extension
17th May 20117:00 amRNSBoard Appointment
16th May 20117:00 amRNSLicence option agreement extension
1st Apr 20113:20 pmRNSGrant of Share Options
18th Mar 20112:20 pmRNSNotifiable Interest - Replacement
18th Mar 20111:19 pmRNSNotifiable Interest
8th Mar 20114:35 pmRNSPrice Monitoring Extension
4th Mar 20112:15 pmRNSNotifiable Interest
1st Mar 20113:24 pmRNSHolding(s) in Company
1st Mar 201110:19 amRNSHolding(s) in Company
28th Feb 20112:22 pmRNSAppointment of joint corporate broker
28th Feb 201112:00 pmRNSTotal Voting Rights
25th Feb 20113:21 pmRNSNotifiable Interest
24th Feb 20115:35 pmRNSNotifiable Interest
23rd Feb 20115:30 pmRNSNotifiable Interest
8th Feb 20115:22 pmRNSNotifiable Interest Correction
8th Feb 20114:00 pmRNSNotifiable Interest
4th Feb 20114:37 pmRNSDirector/PDMR Shareholding
4th Feb 20114:27 pmRNSPublication of Prospectus
4th Feb 20117:00 amRNSProposed Fundraising and IMS
27th Jan 201111:00 amRNSAnnual Information Update
25th Jan 20117:00 amRNSLicence Option Agreement
19th Jan 20114:35 pmRNSPrice Monitoring Extension
14th Jan 20114:40 pmRNSSecond Price Monitoring Extn
14th Jan 20114:35 pmRNSPrice Monitoring Extension
2nd Dec 20104:40 pmRNSSecond Price Monitoring Extn
2nd Dec 20104:35 pmRNSPrice Monitoring Extension
29th Nov 201010:00 amRNSNotice of Results
18th Nov 20102:02 pmRNSBoard appointment
10th Nov 20101:00 pmRNSOngoing communication with Diamond Wood
21st Oct 201011:00 amRNSDiamond Wood
21st Oct 201011:00 amRNSDiamond Wood
19th Oct 20103:00 pmRNSHolding(s) in Company
30th Sep 20102:06 pmRNSBoard Changes
14th Sep 20103:00 pmRNSHolding(s) in Company
18th Aug 20103:03 pmRNSHolding(s) in Company
12th Aug 20102:57 pmRNSHolding(s) in Company
28th Jul 20104:40 pmRNSSecond Price Monitoring Extn
28th Jul 20104:35 pmRNSPrice Monitoring Extension
28th Jul 20101:06 pmRNSAnnual Information Update
27th Jul 201010:37 amRNSGrant of Share Option
27th Jul 201010:31 amRNSResult of AGM
19th Jul 20107:00 amRNSInterim Management Statement
2nd Jul 20107:00 amRNSAnnual Report & Financial Statements & AGM Notice
30th Jun 20107:00 amRNSDiamond Wood AGM
21st Jun 20107:01 amRNSPreliminary Results
21st Jun 20107:00 amRNSStatement re Licensee and board change
18th Jun 20104:35 pmRNSPrice Monitoring Extension
11th Jun 20104:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.